APDN Market Cap History
Below is a table of the APDN market cap history going back to 10/29/2014:

Date APDN Market Cap
10/29/201478.47M
11/17/201467.75M
12/11/201446.91M
2/2/201557.64M
5/8/201552.82M
8/6/201555.22M
12/8/201575.80M
2/5/201672.70M
5/5/201670.30M
8/5/201677.29M
11/28/201661.93M
2/1/201747.43M
5/5/201742.16M
8/7/201745.99M
12/22/201747.88M
2/5/201846.67M
4/30/201845.47M
8/10/201845.17M
12/14/201827.10M
2/1/201914.91M
4/30/201922.35M
8/7/201910.83M

Also see: APDN Shares Outstanding History
and APDN YTD Return
APDN Historical Market Cap:
-33.95% CAGR
APDN Historical Market Cap: +-33.95% CAGR

Mouse over chart for data details
10/29/2014 ...8/7/2019
Applied DNA Sciences is a manufacturer of deoxyribonucleic acid (DNA) for supply chain security, brand protection, law enforcement or drug or biologic applications by using its polymerase chain reaction (PCR) based manufacturing platform. Under its wholly owned subsidiary, LineaRx, Inc., Co. supplies DNA for use in the in vitro medical diagnostics, preclinical biotechnology and preclinical drug and biologic development and manufacturing markets. Co. is also engaged in preclinical and animal drug candidate development directly and with collaborators focusing on therapeutically DNA constructs manufactured via its PCR-based DNA production platform. We show 22 historical shares outstanding datapoints in our APDN shares outstanding history coverage, used to compute APDN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing APDN market cap history over the course of time is important for investors interested in comparing APDN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of APDN versus a peer is one thing; comparing APDN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like APDN can fluctuate over the course of history. With this page we aim to empower investors researching APDN by allowing them to research the APDN market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for APDN:
APDN SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Applied DNA Sciences (APDN) is categorized under the Industrials sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

APH Market Cap History
APWC Market Cap History
AQUA Market Cap History
ARC Market Cap History
ARCB Market Cap History
ARCW Market Cap History
ARII Market Cap History
ARTW Market Cap History
ARTX Market Cap History
ARW Market Cap History
More Industrials companies »

 

APDN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.